Hepatic veno-occlusive disease
ICD-10 K76.5 is a billable code used to indicate a diagnosis of hepatic veno-occlusive disease.
Hepatic veno-occlusive disease (HVOD) is a condition characterized by the obstruction of hepatic venules, leading to hepatic congestion and subsequent liver damage. Clinically, patients may present with symptoms such as jaundice, hepatomegaly, ascites, and abdominal pain. The anatomy involved primarily includes the hepatic veins and the portal venous system, which are crucial for normal liver function and blood flow. Disease progression can vary; in acute cases, symptoms may develop rapidly following exposure to certain toxins, chemotherapy, or following liver transplantation. Chronic cases may lead to cirrhosis and liver failure if not managed appropriately. Diagnostic considerations include imaging studies such as ultrasound, CT, or MRI to assess liver morphology and blood flow, along with liver biopsy to confirm the diagnosis histologically. Laboratory tests may reveal elevated liver enzymes, bilirubin levels, and coagulopathy, which are indicative of liver dysfunction.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
K76.5 specifically covers hepatic veno-occlusive disease, which may arise from various etiologies including chemotherapy, toxins, and certain infections. It is important to differentiate HVOD from other liver conditions such as cirrhosis or portal vein thrombosis.
K76.5 should be used when there is clear evidence of hepatic venous obstruction leading to liver dysfunction, particularly when associated with specific risk factors or clinical presentations that distinguish it from other liver diseases.
Documentation should include clinical findings such as symptoms, imaging studies showing venous obstruction, laboratory results indicating liver dysfunction, and any relevant history of exposure to risk factors like chemotherapy or toxins.
